ID
34533
Beschrijving
Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01443364
Link
https://clinicaltrials.gov/show/NCT01443364
Trefwoorden
Versies (1)
- 19-01-19 19-01-19 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
19 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Rheumatoid Arthritis NCT01443364
Eligibility Rheumatoid Arthritis NCT01443364
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Arthritis
Datatype
boolean
Alias
- UMLS CUI [1]
- C0003864
Beschrijving
Prosthetic joint infection | Communicable Disease
Datatype
boolean
Alias
- UMLS CUI [1]
- C0410808
- UMLS CUI [2]
- C0009450
Beschrijving
Tuberculosis | High risk of Tuberculosis
Datatype
boolean
Alias
- UMLS CUI [1]
- C0041296
- UMLS CUI [2,1]
- C0332167
- UMLS CUI [2,2]
- C0041296
Similar models
Eligibility Rheumatoid Arthritis NCT01443364
- StudyEvent: Eligibility
C0003873 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C1320283 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0005515 (UMLS CUI [1,2])
C0003873 (UMLS CUI [1,3])
C0439849 (UMLS CUI [1,4])
C0009450 (UMLS CUI [2])
C0332167 (UMLS CUI [2,1])
C0041296 (UMLS CUI [2,2])